Shots:
- CereVasc completed enrollment in the ETCHES-1 Study evaluating its eShunt System in adults with communicating hydrocephalus resulting from elevated intracranial pressure following post-aneurysmal subarachnoid hemorrhage
- Study will assess changes in intracranial pressure, device performance & safety, with pts monitored for safety outcomes for up to 24mos. following the procedure
- eShunt System is designed to drain excess CSF from the intracranial subarachnoid space into the venous system using a minimally invasive neuro-interventional procedure, combining a dedicated delivery mechanism with a permanent implant
Ref: PRnewswire | Image: CereVasc | Press Release
Related News: Trisol Medical Reports US Early Feasibility Study Results on Transcatheter Tricuspid Valve Replacement (TTVR) System
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
